- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06188962
Evaluating Knowledge Insight Tools (KIT) for Reducing Anxiety and Low Mood in UK Secondary School Students
A Pragmatic Randomized Multiple Baseline Trial Evaluating Knowledge Insight Tools (KIT), a Cognitive Behavioural Therapy-informed School-based Counselling Intervention for Secondary School-aged Children and Young People With Anxiety and Mood Difficulties in the UK
Background and Study Aims:
Secondary school students are reporting unprecedented levels of anxiety and mood difficulties. To ensure that the needs of all young people are met, there is a need to evaluate more accessible forms of support, such as psychological therapies offered in schools. The aim of this trial is to test a new form of school-based psychological therapy called Knowledge Insight Tools (KIT). KIT is based on Cognitive Behavioural Therapy, which is known to be helpful for young people experiencing difficulties with anxiety and low mood. The investigators want to see whether offering KIT to secondary school students can reduce their anxiety and/or low mood, compared to a period of time when they did not receive any support.
Who can participate?
Children and young people aged 11-18 can participate if they are attending a secondary school in England or Scotland, are experiencing problems with low mood and/or anxiety that are disrupting their everyday lives and are not mainly the result of external factors, and are actively seeking support. Children and young people cannot participate if they pose a significant risk to themselves and/or others, if their primary difficulties are not related to anxiety and/or low mood, if they have significant special educational needs or learning difficulties, and are younger than 16 years and for whom it would pose significant issues if their parents/carers were informed of their involvement with Place2Be services.
What does the study involve?
The study starts with a waiting period, where each young person will not receive any support for 3-8 weeks, except for a weekly check-in with a trained professional. This is meant to provide a stable measurement of young people's mental health before KIT is introduced. The length of the waiting period for each young person is chosen at random by a computer program. This helps mix up the influence of things other than KIT that could impact young people's mental health, such as differences in the natural (and sometimes healing) passage of time. Young people will then be offered 10 sessions of KIT, where they will learn about the ways in which unhelpful thoughts and behaviours can inadvertently make them feel low or anxious. They will also be asked to practice ways of testing their unhelpful thoughts and changing their behaviours outside of sessions, and the investigators will review how this affects their mood and well-being over the course of treatment.
What are the possible benefits and risks of participating?
The main benefit of participating is that young people will be contributing to science, which will help young people struggling with anxiety and mood problems in future be offered forms of school-based psychological therapy that have been rigorously tested. The main risk is that young people might wait longer to start KIT than had they not participated in the study. Young people will still receive KIT if they refuse to participate or withdraw their participation, which they can do at any time.
Where is the study run from?
The study is run from secondary schools in the UK and is being conducted by the Evidence-Based Practice Unit (a research group and collaboration between University College London and the Anna Freud) and researchers and school-based practitioners from Place2Be.
When is the study starting and how long is it expected to run for?
The study started on 01/08/2022 with the recruitment of the first student. The study is expected to run until September 2024. There are plans to extend the study until September 2025 if another wave of recruitment is needed.
Who is funding the study?
The study is funded by Place2Be and Anna Freud, both UK-based charities.
Who is the main contact?
The main contact and principle investigator for the trial is Professor Jessica Deighton (j.deighton@ucl.ac.uk).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jessica Deighton, PhD
- Phone Number: +442077942313
- Email: j.deighton@ucl.ac.uk
Study Contact Backup
- Name: Tanya Lereya, PhD
- Phone Number: 00442077942313
- Email: tanya.lereya@annafreud.org
Study Locations
-
-
-
Multiple Cities Across The UK, United Kingdom, UK
- Recruiting
- Place2Be services within UK schools
-
Contact:
- Hannah Wilkinson, PhD
- Phone Number: +4402079235500
- Email: Hannah.Wilkinson@place2be.org.uk
-
Sub-Investigator:
- Hannah Wilkinson, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 11-18 years old
- Attends a secondary school in England, Scotland or Wales
- Experiencing problems with low mood and/or anxiety that are affecting day-to-day functioning.
- Experiencing problems that are at least in part within their control as opposed to the system being the problem (systems work/advocacy might be more relevant in these cases).
- Are seeking help and are motivated towards change.
Exclusion Criteria:
- Pose a significant risk to themselves and/or others (e.g., where there is significant self-harm [e.g., self-harm that risks accidental death, such as cutting, self-strangulation, under/overusing medications, tablets or substances, and swallowing hazardous materials], suicidal ideation, suicidal intent, sexual/physical violence to/from others, hospitalization due to alcohol/substance misuse/self-harm/psychiatric reasons)
- Are experiencing severe anxiety/mood difficulties, or whose primary difficulties are not related to anxiety/low mood, e.g., uncontrolled eating disorders, substance/alcohol dependence, psychotic disorders, body dysmorphia, antisociality, risk-taking problems, and personality disorders.
- Have significant special educational needs or learning difficulties.
- Are younger than 16 and for whom it would pose significant issues if their parents/carers were informed of their involvement with Place2Be services.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: 3-8 week baseline wait period followed by CBT-informed school-based counselling
All participants undergo a baseline wait period but are randomized to different baseline lengths (3-8 weeks)
|
Knowledge Insight Tools (KIT) is a CBT-based model of one-to-one therapy for secondary school pupils who are struggling with low mood and/or anxiety.
KIT incorporates the key features of CBT (e.g., agenda setting, formulation around maintenance cycles, inter-session work involving exposure and/or behavioural activation) but is delivered in a semi-structured way that meets the young person's needs and pace of learning.
Whilst there is an emphasis on symptom reduction, the primary focus is on the young person's goals for living and co-producing an understanding of how symptoms can interfere with these goals.
Practitioners are encouraged to incorporate different therapeutic tools and modalities that complement the young person's strengths and ways of learning, including non-verbal forms of expression like arts and crafts, music, and dance.
By being flexible, person-led, goal-focused, and integrative, KIT was designed to suit the needs of secondary school students.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Young Person's Clinical Outcomes in Routine Evaluation (YP-CORE)
Time Frame: Assessed at the beginning of each weekly baseline session throughout each participant's 3-8 week baseline wait period, and at the beginning of each weekly intervention session over the 10-week intervention period.
|
Child-reported psychological distress/coping, anxiety, and mood difficulties.
Scores range from 0-40, with higher scores reflecting worse psychological distress.
|
Assessed at the beginning of each weekly baseline session throughout each participant's 3-8 week baseline wait period, and at the beginning of each weekly intervention session over the 10-week intervention period.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Revised Children's Anxiety and Depression Scale (RCADS)
Time Frame: Assessed on the first intervention session, 4th and 7th review sessions during the intervention, and the final intervention session (usually the 10th intervention session but this may vary by participant)..
|
Child-reported anxiety and depression symptoms.
Scores range from 0-141, with higher scores reflecting worse anxiety and depression difficulties.
Raw total and subscale scores are usually converted to T-scores, where T-scores greater than 64 reflect the borderline clinical range, and T-scores above 69 reflect the clinical range.
|
Assessed on the first intervention session, 4th and 7th review sessions during the intervention, and the final intervention session (usually the 10th intervention session but this may vary by participant)..
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Implementation Survey
Time Frame: Completed by practitioners at post-intervention, i.e. after all 10-week interventions are completed
|
Practitioner-reported ratings of KIT's feasibility and acceptability.
Scores range from 0-52, with higher scores reflecting a higher agreement in the feasibility, suitability, and acceptability of KIT.
|
Completed by practitioners at post-intervention, i.e. after all 10-week interventions are completed
|
KIT Fidelity Checklist
Time Frame: Assessed at the end of each weekly intervention session over the 10-week intervention period.
|
Practitioner-reported fidelity in delivering KIT.
The measure is scored based on the incidence of CBT tasks and activities, and is scored as the proportion of CBT tasks and activities that occur throughout each intervention.
|
Assessed at the end of each weekly intervention session over the 10-week intervention period.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5420/004
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on CBT-informed school-based counselling
-
York UniversityCompletedAn Online CBT, Mindfulness Meditation & Yoga (CBT-MY) Intervention for Posttraumatic Stress DisorderPTSD | Posttraumatic Stress DisordersCanada
-
University of AarhusMunicipality of Aarhus; Neighbourhood mothers, GellerupActive, not recruiting
-
Centre for Addiction and Mental HealthCompleted
-
Oslo Metropolitan UniversityUniversity of OsloCompletedObesity | Diabetes Type 2Norway
-
University of MelbourneBeyondblue (The National Depression Initiative)Completed
-
VA Office of Research and DevelopmentRecruiting
-
Massachusetts General HospitalTerminatedFunctional Neurological DisorderUnited States
-
Swinburne University of TechnologyUS Department of Veterans AffairsTerminated
-
University of CologneGerman Federal Ministry of Education and Research; Heinrich-Heine University... and other collaboratorsUnknownSchizophrenia | PsychosisGermany
-
Centers for Disease Control and PreventionProcter and Gamble; Centers for Disease Control and Prevention, China; Zhejiang... and other collaboratorsCompletedInfectious Disease | Absenteeism | Respiratory IllnessChina, Pakistan, Philippines